ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Lung Cancer
Rectal Cancer

Colon Cancer trials near San Antonio, TX, USA:

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

This study will investigate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 in participants with advanced or...

Enrolling
Colorectal Cancer (CRC)
Colon Cancer
Biological: CBI-1214

Phase 1

Cartography Biosciences

San Antonio, Texas, United States and 1 other location

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 16 other locations

This first-in-human study will evaluate safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and pharmacodynamics of ....

Enrolling
Advanced Cancer
Advanced Solid Tumors
Drug: PHN-012

Phase 1

Pheon Therapeutics

San Antonio, Texas, United States and 5 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 15 other locations

The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer...

Enrolling
Metastatic Breast Cancer (HR+/ HER2-)
Triple Negative Breast Cancer
Drug: Cetuximab
Drug: PF-08032562

Phase 1

Pfizer
Pfizer

San Antonio, Texas, United States of America and 2 other locations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting
Any Solid Tumor
Glioma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 32 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutation...

Enrolling
Advanced Solid Tumors
CRC (Colorectal Cancer)
Drug: cetuximab
Drug: ALTA3263

Phase 1

Alterome Therapeutics, Inc.

San Antonio, Texas, United States and 7 other locations

This study is to evaluate the safety, tolerability, and PK profiles of RMC-6291 and RMC-6236 in adults with KRAS G12C-mutated solid tumors....

Enrolling
Non-Small Cell Lung Cancer (NSCLC)
Colorectal Cancer
Drug: Assigned interventions

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 53 other locations

to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...

Enrolling
Advanced Solid Tumor
Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

San Antonio, Texas, United States of America and 57 other locations

inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...

Active, not recruiting
Colorectal Cancer (CRC)
Advanced Solid Tumor
Drug: RMC-6291

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 63 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems